Literature DB >> 22944390

Identifying risk factors for surgical site infections in mastectomy patients using the National Surgical Quality Improvement Program database.

Gabrielle B Davis1, Mirna Peric, Linda S Chan, Alex K Wong, Stephen F Sener.   

Abstract

BACKGROUND: The Centers for Disease Control and Prevention reported that surgical site infections (SSIs) create a significant hospital burden. To date, few multi-institutional studies have been performed to evaluate the risk factors for SSIs in mastectomy patients.
METHODS: By using the American College of Surgeons' National Surgical Quality Improvement Program database, all patients undergoing mastectomy from 2005 to 2009 were identified. The outcome was to determine the incidence rate and identify significant independent risk factors of SSIs.
RESULTS: The incidence of SSI was 2.3% (891 of 38,739; 95% confidence interval, 2.2%-2.5%) in patients undergoing mastectomy without reconstruction. Significant (P < .05) risk factors for SSI included a body mass index greater than 25, American Society of Anesthesiology classification of 3 or higher, diabetes mellitus, surgical time of 2 hours or longer (75th percentile), and current smoking status.
CONCLUSIONS: Before this study, there was wide variation in the incidence rate of surgical site infections in this patient population. This was a large-scale study to address these inconsistencies. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22944390     DOI: 10.1016/j.amjsurg.2012.05.007

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  19 in total

1.  Pre-Existing Diabetes in Early Stage Breast Cancer Patients is Associated with Lack of Improvement in Quality of Life 2 Years After Diagnosis.

Authors:  Soghra Jarvandi; Maria Pérez; Mario Schootman; Donna B Jeffe
Journal:  Int J Behav Med       Date:  2016-12

2.  Alcohol consumption does not increase the risk of surgical wound complications in breast cancer patients.

Authors:  Raquel Ferreira de Menezes; Anke Bergmann; Luiz Claudio Santos Thuler
Journal:  Int Wound J       Date:  2020-07-27       Impact factor: 3.315

3.  Surveillance and Prevention of Surgical Site Infections in Breast Oncologic Surgery with Immediate Reconstruction.

Authors:  Margaret A Olsen; Katelin B Nickel; Ida K Fox
Journal:  Curr Treat Options Infect Dis       Date:  2017-05-11

4.  THE EPIDEMIOLOGY AND OUTCOMES OF BREAST CANCER SURGERY.

Authors:  Victoria J Fraser; Katelin B Nickel; Ida K Fox; Julie A Margenthaler; Margaret A Olsen
Journal:  Trans Am Clin Climatol Assoc       Date:  2016

5.  Efficacy of prophylactic antibiotic use in breast cancer surgery in obese patients.

Authors:  Dinesh Thekkinkattil
Journal:  Gland Surg       Date:  2013-05

6.  Variations in postoperative complications according to race, ethnicity, and sex in older adults.

Authors:  J Margo Brooks Carthon; Olga Jarrín; Douglas Sloane; Ann Kutney-Lee
Journal:  J Am Geriatr Soc       Date:  2013-09-05       Impact factor: 5.562

Review 7.  Anesthesia, microcirculation, and wound repair in aging.

Authors:  Itay Bentov; May J Reed
Journal:  Anesthesiology       Date:  2014-03       Impact factor: 7.892

8.  Surgical site infections (SSIs) after stoma reversal (SR): risk factors, implications, and protective strategies.

Authors:  Daniel I Chu; Christopher R Schlieve; Dorin T Colibaseanu; Paul J Simpson; Amy E Wagie; Robert R Cima; Elizabeth B Habermann
Journal:  J Gastrointest Surg       Date:  2014-09-13       Impact factor: 3.452

9.  Surgical site infection after thyroidectomy: a rare but significant complication.

Authors:  Dawn M Elfenbein; David F Schneider; Herbert Chen; Rebecca S Sippel
Journal:  J Surg Res       Date:  2014-03-19       Impact factor: 2.192

10.  Development of a Risk Prediction Model to Individualize Risk Factors for Surgical Site Infection After Mastectomy.

Authors:  Margaret A Olsen; Katelin B Nickel; Julie A Margenthaler; Ida K Fox; Kelly E Ball; Daniel Mines; Anna E Wallace; Graham A Colditz; Victoria J Fraser
Journal:  Ann Surg Oncol       Date:  2016-01-28       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.